Ultragenyx Pharmaceutical Inc.RARENASDAQ
Loading
Debt to Assets Over TimeElevated
Percentile Rank100
3Y CAGR+244.1%
5Y CAGR+97.9%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
+244.1%/yr
Annual compound
5Y CAGR
+97.9%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
30.4x
Strong expansion
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.83 | +3004.3% |
| 2024 | 0.03 | -7.3% |
| 2023 | 0.03 | +41.6% |
| 2022 | 0.02 | -25.8% |
| 2021 | 0.03 | +0.6% |
| 2020 | 0.03 | -15.9% |
| 2019 | 0.03 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |